NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)
ID: 359655Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $200K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359655

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-26-011.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for the NIA Expanding Research in Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) Summer Research Education Program (R25). This program aims to support the development and implementation of summer research education experiences for high school students, undergraduates, and science teachers, particularly those from underrepresented backgrounds, to enhance the research workforce in the AD/ADRD field. The initiative is crucial for providing early exposure to AD/ADRD research and encouraging participants to pursue careers in biomedical and behavioral sciences. Up to five awards of $200,000 in direct costs per year for up to five years are anticipated, with applications due by May 26, 2027. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-AG-26-011-Full-Announcement.html
    RFA-AG-26-011.html
    The Department of Health and Human Services (HHS), through the National Institute on Aging (NIA), is reissuing a Funding Opportunity Announcement (RFA-AG-26-011) for the NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25). This program supports summer research experiences for high school students, undergraduates, or science teachers to expand the Alzheimer's Disease (AD) and Alzheimer's Disease Related Dementias (ADRD) research workforce. The NOFO aims to provide early exposure to AD/ADRD research and encourage participants to pursue related careers. Up to five new awards of $200,000 direct costs per year for up to five years are anticipated for FY 2027 and FY 2028. Applications are due by May 27, 2026, and will be evaluated based on significance, investigator qualifications, innovation, approach, and institutional environment. Clinical trials are not allowed, but participants can gain experience in mentor-led trials. Foreign organizations are ineligible.
    Similar Opportunities
    NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25), aimed at enhancing training for a skilled workforce in Alzheimer's Disease (AD) and Alzheimer's Disease and Related Dementias (ADRD). This program seeks to support educational activities that provide intensive research experiences for recent baccalaureates, particularly those from underrepresented backgrounds, to prepare them for advanced degree programs or research careers in AD/ADRD. The NIH plans to commit $2,000,000 in FY 2027 and FY 2028 to fund up to five new awards annually, with a maximum project period of five years and direct costs of up to $400,000 per year. Interested applicants can find more information and application details at the provided link and should direct inquiries to grantsinfo@nih.gov, with applications due by May 26, 2027.
    Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) aimed at enhancing educational activities in biomedical, behavioral, and clinical research. This program specifically targets high school and undergraduate students, as well as science teachers, providing them with hands-on research experiences during the summer academic break, while fostering diversity and inclusion in research. Applicants can request funding up to $125,000 per year, with proposals due by March 17, 2027, and are encouraged to align their programs with the specific mission areas of the participating NIH institutes. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-204.html.
    NIA MSTEM: Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Diversity in Aging Research (ADAR) through Undergraduate Education," aimed at enhancing diversity in aging-related research fields. This initiative invites applications for research education programs that provide undergraduate students from underrepresented backgrounds with structured research experiences in aging, with the goal of preparing them for advanced degrees or careers in this discipline. The program emphasizes the importance of recruiting participants from diverse settings and requires a detailed recruitment plan, collaboration with existing NIH-funded programs, and comprehensive evaluation strategies. The funding limit is set at $375,000 per year, with a maximum project period of five years, and applications are due by May 25, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)." This initiative aims to develop a diverse, interdisciplinary workforce capable of conducting translational research on AD and ADRD, supporting training programs for predoctoral and postdoctoral researchers with varied educational backgrounds. The program emphasizes the importance of interdisciplinary collaboration and aims to enhance understanding and treatment of aging-related health issues. NIH plans to award an estimated 3-5 grants annually over the next three years, with a total budget of $2.7 million, and applications are due by September 25, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), is offering a Small Research Grant Program (R03) aimed at fostering the next generation of researchers in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This program supports innovative projects that enhance understanding, diagnosis, treatment, and care strategies for AD/ADRD, while also promoting workforce diversity and addressing health disparities in this field. Grants of up to $100,000 for a duration of two years are available, with a total of 12 awards expected for fiscal year 2024, amounting to $1.8 million in funding. Interested applicants must be affiliated with eligible organizations and are encouraged to submit their applications by March 16, 2026, with inquiries directed to grantsinfo@nih.gov for further information.
    Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)" aimed at developing a diverse and interdisciplinary workforce for translational research in this critical health area. The initiative invites eligible institutions to create training programs for predoctoral and postdoctoral researchers, focusing on enhancing skills in data science, disease biology, and drug discovery, while not permitting independent clinical trials. With an anticipated budget of approximately $2.7 million annually for 3-5 awards over fiscal years 2025-2027, applications are due by September 25, 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced the "Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)." This program aims to support innovative research projects focused on Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD), specifically targeting early-stage and diverse researchers who have not previously received significant NIH funding in this field. The initiative is designed to generate pilot data that can lead to larger funding applications, thereby enhancing research capabilities and workforce diversity in biomedical research. Grants of up to $100,000 per year for two years are available, with the application process opening on January 16, 2025, and the closing date set for March 16, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Neurological Disorders and Stroke (NINDS), has announced a funding opportunity titled "NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)" aimed at enhancing research education in biomedical, behavioral, and clinical research. This initiative seeks applications for innovative educational activities that provide hands-on research experiences and skills development, particularly in the field of neuroscience, with a maximum funding of $250,000 per year for up to five years. The program emphasizes diversity recruitment and significant institutional commitment, requiring applicants to include a comprehensive evaluation plan and adhere to strict guidelines. Interested parties can find more information and apply by July 14, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)" aimed at advancing exploratory research in Alzheimer's disease (AD) and related dementias (ADRD). This initiative invites applications for innovative methodologies, animal models, and techniques that require preliminary data, with a focus on addressing health disparities among under-resourced populations. The program emphasizes the importance of interdisciplinary research to combat the public health crisis posed by AD and ADRD, with a maximum funding amount of $275,000 available over two years. Interested applicants must submit their proposals by November 16, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F31 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Predoctoral Fellowship Award aimed at promoting diversity in the translational research workforce focused on Alzheimer's disease and related dementias (AD/ADRD). This grant supports promising predoctoral candidates from diverse backgrounds in acquiring essential translational research skills, with an emphasis on interdisciplinary approaches to AD/ADRD research, although independent clinical trials are not permitted. The initiative is crucial for fostering a diverse pool of trained scientists capable of addressing the biomedical and social challenges associated with aging and dementia. The total funding available is $335,000 for six anticipated awards, with key application deadlines starting on March 8, 2025, and the final close date set for December 8, 2027. For more information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-333.html.